Stocks · News reference

Dyadic International Inks New Development, Commercial License Agreement With European Biotechnology Firm For Additional Precision Fermented Dairy Proteins

Aug 4, 2026, 11:27 AMBenzinga Newsdesk

Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences, food

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DYAI

Source: benzinga
Observed: Aug 4, 2026, 11:27 AM
Checked: Aug 4, 2026, 11:27 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

SEC EDGARAug 14, 2026, 1:17 PMSEC EDGAR
8-K filing — DYADIC INTERNATIONAL INC (DYAI)
Filed: 2026-08-14 AccNo: 0001493152-26-038039 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgar
DYAI
BenzingaAug 13, 2026, 4:16 PMBenzinga Newsdesk
Dyadic International shares are trading lower after the company announced a $2.9 million offering and concurrent private placement.
Read original at benzinga
DYAI
BenzingaAug 13, 2026, 12:07 PMBenzinga Newsdesk
Dyadic International Announces Definitive Agreements For $2.9M Registered Direct Offering And Concurrent Private Placement Of Warrants With Institutional Investor
Dyadic International, Inc. (NASDAQ:DYAI) (the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences, food and nutrition,
Read original at benzinga
DYAI
BenzingaAug 12, 2026, 4:32 PMBenzinga Newsdesk
Dyadic International shares are trading lower after the company reported worse-than-expected Q2 financial results.
Read original at benzinga
DYAI

Dyadic International Inks New Development, Commercial License Agreement With European Biotechnology Firm For Additional Precision Fermented Dairy Proteins

Connected markets

Related headlines

8-K filing — DYADIC INTERNATIONAL INC (DYAI)

Dyadic International shares are trading lower after the company announced a $2.9 million offering and concurrent private placement.

Dyadic International Announces Definitive Agreements For $2.9M Registered Direct Offering And Concurrent Private Placement Of Warrants With Institutional Investor

Dyadic International shares are trading lower after the company reported worse-than-expected Q2 financial results.